Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies
Dong Xi, Henry Lin, Amit A. Shah – 21 July 2022
Dong Xi, Henry Lin, Amit A. Shah – 21 July 2022
Ellen W. Green, Arnab Mitra – 21 July 2022
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 20 July 2022
Randa Elsheikh, Hoang Thuy Tien, Abdelrahman M. Makram, Nguyen Thanh Van, Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Tien Huy – 20 July 2022 – Since April 2022, the world has been witnessing a rapidly spreading outbreak of acute hepatitis of unknown origin in children < 16 years old that has affected several countries around the world. Most of the cases have presented with the clinical picture of severe hepatitis that has led to resorting to liver transplantation in several cases.
Kwang Yoon Kim, Kyung‐Won Hong, Bom Taeck Kim – 20 July 2022
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak – 20 July 2022
Shikai Hu, Catherine Cao, Minakshi Poddar, Evan Delgado, Sucha Singh, Anya Singh‐Varma, Donna Beer Stolz, Aaron Bell, Satdarshan P. Monga – 20 July 2022
Stephanie S. Maldonado, Joshua Grab, Connie W. Wang, Heather Huddleston, Marcelle Cedars, Monika Sarkar – 20 July 2022 – Polycystic ovary syndrome (PCOS) occurs in approximately 10% of all reproductive‐age women, with over 50% of these patients having imaging‐confirmed nonalcoholic fatty liver disease (NAFLD). Whether PCOS increases the risk for more clinically relevant disease, such as nonalcoholic steatohepatitis (NASH), is unclear. Such findings are relevant to prognosticating risk of progressive liver disease in the growing population of young adults with NAFLD.
Junwei Zhang, Yiyao Xu, Xin Lu, Haitao Zhao – 20 July 2022
Cong Ning, Shi‐Tao Jiang, Xin‐Ting Sang – 20 July 2022